Ultimately, we found that the expression of hepatic CD11b+CD33+ MDSCs was increased in chronic liver diseases such as autoimmune hepatitis and hepatocellular carcinoma and positively correlated with the liver stages of hepatitis activity or liver fibrosis stage. The gene discussed is CD33; the disease is Hepatic fibrosis.